Authors
Loading...
Genetically engineered mouse models show that KRASG12R alters tumor behavior and microenvironment in pancreatic cancer, suggesting new therapeutic targets.
Burge et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: